Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Outcomes
Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Oct 20, 2011
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older than 15 years old;
- • Nasal obstruction and nasal aesthetics complaints;
- Exclusion Criteria:
- • Previous septoplasty, turbinates intervention and/or rhinoplasty;
- • Association of other surgical procedures in the same surgical time, as functional endoscopic sinus surgery, blepharoplasty, mentoplasty or otoplasty;
- • Inferior turbinate hypertrophy as the isolated cause of nasal obstruction (no septum deviation or internal valve collapse)
About Hospital De Clinicas De Porto Alegre
Hospital de Clínicas de Porto Alegre (HCPA) is a leading academic medical center in Brazil, renowned for its commitment to advancing healthcare through innovative clinical research. As a sponsor of clinical trials, HCPA leverages its extensive expertise in various medical disciplines to conduct rigorous studies aimed at improving patient outcomes and contributing to the global medical community. With a multidisciplinary team of skilled professionals and state-of-the-art facilities, HCPA fosters a collaborative environment that prioritizes ethical standards, patient safety, and scientific integrity in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rio Grande Do Sul, Brazil
Patients applied
Trial Officials
Michelle L Wolff
Principal Investigator
Hospital de Clinicas de Porto Alegre/ Universidade Federal do Rio Grande do Sul
Carisi A Polanczyck, PhD
Study Chair
Federal University of Rio Grande do Sul
José E Dolci, PhD
Study Chair
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials